Read More Pharma Industry News Could one hair loss antibody make Absci’s AI drug platform harder to ignore? Absci’s ABS-201 data and $100 million raise sharpen ABSI’s AI biologics story across androgenetic alopecia, endometriosis and platform validation. bySoujanya RaviJune 26, 2026